Six-year results of spironolactone and testolactone treatment of familial male-limited precocious puberty with addition of deslorelin after central puberty onset

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 1, 1999, Pages 175-178

  Leschek, Ellen Werber ^a   Jones, Janet ^a   Barnes, Kevin M ^a   Hill, Suvimol C ^b   Cutler Jr , Gordon B ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DESLORELIN; GONADORELIN; KETOCONAZOLE; SPIRONOLACTONE; TESTOLACTONE;

ARTICLE; BODY HEIGHT; BONE MATURATION; CHILD; CLINICAL ARTICLE; DRUG EFFECT; DRUG SAFETY; FAMILIAL DISEASE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GROWTH RATE; HUMAN; LIVER TOXICITY; LONG TERM CARE; MALE; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0032957734     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.84.1.5413     Document Type: Article

References (26)

1. 1. Schedewie HK, Reiter EO, Beitins IZ, et al. 1981 Testicular Leydig cell hyperplasia as a cause of familial sexual precocity. J Clin Endocrinol Metab. 52:271-278.
2. 2. Rosenthal SM, Grumbach MM, Kaplan SL. 1983 Gonadotropin-independent familial sexual precocity with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent luteinizing hormone-releasing factor agonist and medroxyprogesterone acetate therapy in four cases. J Clin Endocrinol Metab. 57:571-579.
3. 3 Reiter EO, Brown RS, Longcope C, Beitins IZ. 1984 Male-limited familial precocious puberty in three generations apparent Leydig-cell autonomy and elevated glycoprotein hormone alpha subunit. N Engl J Med. 311:515-519.
4. 4. Egli CA, Rosenthal SM, Grumbach MM, Montalvo JM, Gondos B. 1985 Pituitary gonadotropin-independent male-limited autosomal dominant sexual precocity in 4 generations: "familial testotoxicosis." J Pediatr. 106:33-40.
5. 5. Beas F, Zurbrugg RP, Leibow SG, Patton RG, Gardner LI. 1962 Familial male sexual precocity: report of the eleventh kindred found with observations on blood group linkage and urinary C19-steroid excretion. J Clin Endocrinol Metab. 22:1095-1102.
6. 6. Shenker A, Laue L, Kosugi S, Merendino JJ, Minegishi T, Cutler GB. 1993 A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature. 365:652-654.
7. 7. Wierman ME, Beardsworth DE, Mansfield MJ, et al. 1985 Puberty without gonadotropins: a unique mechanism of sexual development. N Engl J Med. 312:65-72.
8. 8. Itoh K, Nakada T, Kubota Y, Suzuki H, Ishigooka M, Izumi T. 1996 Testotoxicosis proved by immunohistochemical analysis and successfully treated with cyproterone acetate. Urol Int. 57:199-202.
9. 9. Holland FJ, Fishman L, Bailey JD, Fazekas ATA. 1985 Ketoconazole in the management of precocious puberty not responsive to LHRH-analogue therapy. N Engl J Med. 312:1023-1028.
10. 10. Root AW, Zamanillo J, Duckett G, Sweetland M. 1986 Gonadotropin-indeendent isosexual precocity in a boy with tuberous sclerosis: effect of ketoconazole. J Pediatr. 109:1012-1015.
11. 11. Holland FJ, Kirsch SE, Selby R. 1987 Gonadotropin-independent precocious puberty ("testotoxicosis"): influence of maturational status on response to ketoconazole. J Clin Endocrinol Metab. 64:328-333.
12. 12. Santen RJ, Van den Bossche H, Symoens J, Brugmans J, DeCoster R. 1983 Site of action of low dose ketoconazole on androgen biosynthesis in men. J Clin Endocrinol Metab. 57:732-736.
13. 13. Schurmeyer T, Nieschlag E. 1984 Effect of ketoconazole and other imidazole fungicides on testosterone biosynthesis. Acta Endocrinol (Copenh). 105:275-280.
14. 14. Lewis JH, Zimmerman HJ, Benson GD, Ishak KG. 1984 Hepatic injury associated with ketoconazole therapy: analysis of 33 cases. Gastroenterology. 86:503-513.
15. 15. Stricker BHCh, Blok APR, Bronkhorst FB, Van Parys GE, Desmet VJ. 1986 Ketoconazole-associated hepatic injury: a clinicopathological study of 55 cases. J Hepatol. 3:399-406.
16. 16. Babovic-Vuksanovic D, Donaldson MDC, Gibson NA, Wallace AM. 1994 Hazards of ketoconazole therapy in testotoxicosis. Acta Paediatr. 883:994-997.
17. 17. Laue L, Kenigsberg D, Pescovitz OH, Hench KD, Barnes KM, Loriaux DL, Cutler Jr GB. 1989 Treatment of familial male precocious puberty with spironolactone, and testolactone. N Engl J Med. 320:496-502.
18. 18. Laue L, Jones J, Barnes KM, Cutler Jr GB. 1993 Treatment of familial male precocious puberty with spironolactone, testolactone, and deslorelin. J Clin Endocrinol Metab. 76:151-155.
19. 19. Smith EP, Boyd J, Frank GR, et al. 1994 Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med. 331:1056-1061.
20. 20. Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K. 1995 Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab. 80:3689-3698.
21. 21. Greulich WW, Pyle SI. 1985 Radiographic skeletal development of the hand and wrist. Stanford: Stanford University Press.
22. 22 Zachmann M, Sabradillo B, Frank M, Frisch H, Prader A. 1978 Bailey-Pinneau Roche-Weiner-Thissen and Tanner height predictions in normal children and in patients with various pathologic conditions. J Pediatr. 93:749-755.
23. 23. Zachmann M, Prader A, Kind HP, Hafliger H, Budliger H. 1974 Testicular volume during adolescence: cross-sectional and longitudinal studies. Helv Paediatr Acta. 29:61-72.
24. 24. Tanner JM. 1962 Growth at adolescence, 2nd ed. Springfield: Thomas.
25. 25. Odell WD, Ross GT, Rayford PL. 1967 Radioimmunoassay for luteinizing hormone in human plasma or serum: physiological studies. J Clin Invest. 46:248-255.
26. 26. Cargille CM, Rayford PL. 1970 Characterization of antisera for human follicle-stimulating hormone radioimmunoassay. J Lab Clin Med. 75:1030-1040.